TransMedics Group Inc

20. Okt. 2026, 20:01 UTC

TransMedics Group Inc is positioned to benefit from the Trump administration's proposed kidney care plan aimed at enhancing competition and innovation in kidney treatment.

16. Okt. 2026, 20:02 UTC

Transmedics Group Inc shares are declining, reversing a trend of higher daily closes that persisted since Thursday's close.

15. Okt. 2026, 19:46 UTC

Stifel projects Transmedics Group Inc. will report third-quarter revenue between $185 million and $190 million, exceeding the Street's estimate of $178 million.

14. Okt. 2026, 20:07 UTC

Transmedics Group Inc shares fell sharply, closing significantly lower compared to Tuesday's close and reaching a low around midday.

13. Okt. 2026, 20:02 UTC

Canaccord Genuity maintains Buy rating on TransMedics Group Inc while lowering price target to $94.00, reflecting ongoing confidence in the company's prospects.

9. Okt. 2026, 20:06 UTC

Transmedics Group Inc shares are declining, unable to sustain an early spike, and are currently positioned significantly below their 20-day moving average.

8. Okt. 2026, 20:07 UTC

Transmedics Group Inc shares declined sharply on Thursday, finishing notably lower and remaining substantially below their 20-day moving average.

7. Okt. 2026, 19:50 UTC

TransMedics Group Inc. advanced after Barclays initiated coverage with an Overweight rating and a $120 price target, despite earlier pulling back from a session high.

5. Okt. 2026, 20:06 UTC

Transmedics Group Inc shares rose following Piper Sandler's initiation of coverage with an "Overweight" rating and a $100 price target.

2. Okt. 2026, 20:07 UTC

Transmedics Group Inc is gaining amid a broader market rally, driven by falling U.S. Treasury yields and improved investor sentiment since Thursday's close.

1. Okt. 2026, 20:02 UTC

Transmedics Group Inc shares fell sharply, reversing a recent trend of higher daily closes amid a shift in the asset's performance.

30. Sept. 2026, 19:15 UTC

Transmedics Group Inc shares fell after an early rise, currently trading below the 20-day moving average and near the lower end of its one-month range.

29. Sept. 2026, 19:45 UTC

Transmedics Group Inc is trading higher, rebounding from an early dip, although it remains below its 20-day moving average and near the lower end of its one-month range.

25. Sept. 2026, 20:07 UTC

Transmedics Group Inc. shares rose following Canada's first Organ Care System heart transplant, expected to boost donor heart availability by 40%.

24. Sept. 2026, 20:07 UTC

Transmedics Group Inc shares fell sharply, continuing a downward trend from Wednesday and finishing significantly below its 20-day moving average.

23. Sept. 2026, 20:07 UTC

Transmedics Group Inc shares fell amid a broader market decline, despite reaffirming 2026 revenue guidance of $737 million to $757 million.

22. Sept. 2026, 19:15 UTC

Transmedics Group Inc. appointed Fernando Araujo as CFO and reaffirmed 2026 revenue guidance of $737M to $757M, with shares trading higher.

21. Sept. 2026, 20:06 UTC

Transmedics Group Inc is trading higher following validation from a federal agency and a $7.27M contract for liver recovery services from Veterans Integrated Service Network 4.

18. Sept. 2026, 20:06 UTC

Transmedics Group Inc shares fell, closing below Thursday's level after fluctuating throughout the day, marking three consecutive sessions of lower closes.

17. Sept. 2026, 20:07 UTC

Transmedics Group Inc shares fell Thursday, declining from Wednesday's close despite a brief earlier rebound, amid overall lower market performance.

16. Sept. 2026, 20:10 UTC

Transmedics Group Inc shares fell modestly amid a broader market decline, stabilizing near the midpoint of its one-month range.

15. Sept. 2026, 20:07 UTC

TransMedics Group shares are rising following an insider purchase by Director David Weill at $81.63, amid positive social media discussions about the company.

14. Sept. 2026, 20:03 UTC

TransMedics Group Inc shares are gaining during Monday's session, despite earlier pullbacks. Broader market volatility is influenced by rising crude oil prices and inflation concerns.

11. Sept. 2026, 20:02 UTC

TransMedics Group Inc shares are lower following the announcement of a CFO transition. The company reaffirmed its 2026 revenue guidance of $737 million to $757 million.

10. Sept. 2026, 20:06 UTC

Transmedics Group Inc shares are lower amid broader market pressure, reflecting ongoing concerns over rising Treasury yields and inflation. No specific company news was identified.

9. Sept. 2026, 20:07 UTC

Transmedics Group Inc shares are lower today, breaking a recent trend despite positive sentiment reported by Jefferies' Transplant Tracker earlier this month.

8. Sept. 2026, 19:56 UTC

Transmedics Group reported EPS of $0.44 but lowered its adjusted operating margin guidance, contributing to a decline in shares since Friday's close.

4. Sept. 2026, 20:07 UTC

Transmedics Group reported Q2 EPS of $0.44, missing estimates. The company raised its 2026 revenue outlook, boosting investor sentiment and shares during Friday's session.

2. Sept. 2026, 19:56 UTC

Transmedics Group Inc shares are trading higher today, reflecting notable intraday volatility amid rising U.S. Treasury yields and broader market fluctuations.

1. Sept. 2026, 20:09 UTC

Transmedics Group Inc shares declined during Tuesday's session, reaching a low before a slight recovery. The stock remains below its 20-day moving average.